These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18261511)

  • 21. VSMP: a novel variable selection and modeling method based on the prediction.
    Liu SS; Liu HL; Yin CS; Wang LS
    J Chem Inf Comput Sci; 2003; 43(3):964-9. PubMed ID: 12767155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new and efficient variable selection algorithm based on ant colony optimization. Applications to near infrared spectroscopy/partial least-squares analysis.
    Allegrini F; Olivieri AC
    Anal Chim Acta; 2011 Aug; 699(1):18-25. PubMed ID: 21704753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LIV-3D-QSAR models for PGI2 receptor ligands using multiple conformations.
    Azevedo Martins RC; Girão Albuquerque M; Bicca de Alencastro R
    Eur J Med Chem; 2004 Apr; 39(4):359-67. PubMed ID: 15072844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A tentative quantitative structure-toxicity relationship study of benzodiazepine drugs.
    Funar-Timofei S; Ionescu D; Suzuki T
    Toxicol In Vitro; 2010 Feb; 24(1):184-200. PubMed ID: 19765642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of mutual information and genetic programming for feature selection in QSAR.
    Venkatraman V; Dalby AR; Yang ZR
    J Chem Inf Comput Sci; 2004; 44(5):1686-92. PubMed ID: 15446827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranking of aquatic toxicity of esters modelled by QSAR.
    Papa E; Battaini F; Gramatica P
    Chemosphere; 2005 Feb; 58(5):559-70. PubMed ID: 15620749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robust cross-validation of linear regression QSAR models.
    Konovalov DA; Llewellyn LE; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Oct; 48(10):2081-94. PubMed ID: 18826208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative QSAR studies on toxicity of phenol derivatives using quantum topological molecular similarity indices.
    Hemmateenejad B; Mehdipour AR; Miri R; Shamsipur M
    Chem Biol Drug Des; 2010 May; 75(5):521-31. PubMed ID: 20486939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QSAR study of angiotensin II antagonists using robust boosting partial least squares regression.
    Zhou YP; Cai CB; Huan S; Jiang JH; Wu HL; Shen GL; Yu RQ
    Anal Chim Acta; 2007 Jun; 593(1):68-74. PubMed ID: 17531825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jackknife-based selection of Gram-Schmidt orthogonalized descriptors in QSAR.
    Kompany-Zareh M; Omidikia N
    J Chem Inf Model; 2010 Dec; 50(12):2055-66. PubMed ID: 21069957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel descriptor of amino acids and its application in peptide QSAR.
    Tong J; Liu S; Zhou P; Wu B; Li Z
    J Theor Biol; 2008 Jul; 253(1):90-7. PubMed ID: 18397794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studying the explanatory capacity of artificial neural networks for understanding environmental chemical quantitative structure-activity relationship models.
    Yang L; Wang P; Jiang Y; Chen J
    J Chem Inf Model; 2005; 45(6):1804-11. PubMed ID: 16309287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. McQSAR: a multiconformational quantitative structure-activity relationship engine driven by genetic algorithms.
    Vainio MJ; Johnson MS
    J Chem Inf Model; 2005; 45(6):1953-61. PubMed ID: 16309302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus QSAR models: do the benefits outweigh the complexity?
    Hewitt M; Cronin MT; Madden JC; Rowe PH; Johnson C; Obi A; Enoch SJ
    J Chem Inf Model; 2007; 47(4):1460-8. PubMed ID: 17616180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QSAR study of PETT derivatives as potent HIV-1 reverse transcriptase inhibitors.
    Sabet R; Fassihi A; Moeinifard B
    J Mol Graph Model; 2009 Sep; 28(2):146-55. PubMed ID: 19570701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling structure-activity relationships of prodiginines with antimalarial activity using GA/MLR and OPS/PLS.
    de Campos LJ; de Melo EB
    J Mol Graph Model; 2014 Nov; 54():19-31. PubMed ID: 25244636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward robust QSPR models: Synergistic utilization of robust regression and variable elimination.
    Grohmann R; Schindler T
    J Comput Chem; 2008 Apr; 29(6):847-60. PubMed ID: 17963234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.
    Nunthanavanit P; Anthony NG; Johnston BF; Mackay SP; Ungwitayatorn J
    Arch Pharm (Weinheim); 2008 Jun; 341(6):357-64. PubMed ID: 18442018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.